Innovent Biologics Enters Key Indices，Signifying Global Recognition of China's Biopharma Leader
Innovent Biologics, a global leader in innovative biopharmaceuticals, has successfully been added to the Hang Seng Index, Hang Seng China Enterprises Index, and Hang Seng ESG Enhanced Index. This milestone underscores the company's rising prominence in the global capital markets and highlights its strong position as a leader in the biopharmaceutical industry.
Via News Editorial•
